Paion UK Ltd.

Quick facts

Phase 3 pipeline

• Morphine 6-glucuronide · Pain Management
  Morphine 6-glucuronide is an active metabolite of morphine that binds to opioid receptors in the central nervous system to produce analgesia and other opioid effects.

Phase 2 pipeline

• A. CNS 7056 · Pain
  CNS 7056 is a kappa opioid receptor antagonist.
• B. CNS 7056
  B. CNS 7056 is an investigational drug with a mechanism that is not fully disclosed publicly.
• C. CNS 7056
• CNS 7056 · Pain
  CNS 7056 is a kappa opioid receptor antagonist.
• D. Midazolam · Oncology
  GABA_A receptor agonist

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Paion UK Ltd. portfolio CI brief
• Paion UK Ltd. pipeline updates RSS